Chardan Capital Issues Pessimistic Forecast for Forte Biosciences (NASDAQ:FBRX) Stock Price
Forte Biosciences (NASDAQ:FBRX – Get Free Report) had its price objective lowered by equities research analysts at Chardan Capital from $64.00 to $61.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Separately, TD Cowen initiated coverage on shares of Forte Biosciences in a research […]
Forte Biosciences (NASDAQ:FBRX – Get Free Report) had its price objective lowered by equities research analysts at Chardan Capital from $64.00 to $61.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Separately, TD Cowen initiated coverage on shares of Forte Biosciences in a research […]
